IT
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni & Conferenze
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
Contatto
TeamExpertise
NewsRankings & AwardsPubblicazioni & Conferenze
Chi siamoCarrieraContatto
de|fr|it|en
DEFREN
de|fr|it|en
Basilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion ZurigoBasilea Berna Binningen China Desk Ginevra Gstaad Japan Desk Losanna Lugano Sion Zurigo
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni & Conferenze
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026
  • Team
  • Expertise
  • News
  • Rankings & Awards
  • Pubblicazioni & Conferenze
  • Chi siamo
  • Carriera
  • Contatto
  • LinkedIn
  • Instagram
Imprint–Terms of use–Privacy notice–Cookie policy–
© 2026

Deals & Cases

Marco Sibold
  • Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.Kellerhals Carrard advises eps Holding GmbH on the combination of the eps Event Group and NÜSSLI (Switzerland) Ltd.27 agosto 2026
  • Kellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative AdvisorsKellerhals Carrard berät Eigentümer der Tretor AG bei Transaktion mit Pictet Alternative Advisors11 marzo 2026
  • Deal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA TherapeuticsDeal Ticker: Kellerhals Carrard advised Sofinnova Partners and Earlybird Venture Capital on financing round with HAYA Therapeutics15 maggio 2025
  • Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.Kellerhals Carrard Advised MoonLake Immunotherapeutics on Debt Financing with Hercules Capital, Inc.4 aprile 2025
  • Deal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AGDeal Ticker: Kellerhals Carrard berät Orell Füssli bei der Übernahme der Verlag SKV AG13 marzo 2025
  • Kellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos PharmaKellerhals Carrard Advises on the Sale of Baccinex S.A. to Adragos Pharma3 dicembre 2024
  • Deal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AGDeal Ticker: Kellerhals Carrard Advises Rhenopharma Group in Acquisition of Konapharma AG28 giugno 2024
  • Deal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AGDeal Ticker: Kellerhals Carrard Advised on Acquisition of Majority Stake in Walter Meier (Fertigungslösungen) AG27 maggio 2024
  • Deal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOSTDeal Ticker: Kellerhals Carrard advised Aitonomi in intensified strategic partnership by JOST22 maggio 2024
  • Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.Deal Ticker: Novartis hands over the Life-Science-Park Rhine Valley to GETEC Switzerland.23 agosto 2023
  • Deal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AGDeal Ticker: Kellerhals Carrard advised palero on the acquisition of Fischer Söhne AG9 agosto 2023
  • Deal Ticker: Kellerhals Carrard advised on sale of Franz Carl WeberDeal Ticker: Kellerhals Carrard advised on sale of Franz Carl Weber5 luglio 2023